ocrelizumab (ocrevus) Report issue

Biologics mAb Approved FDA First in Class Fast Track FDA
AACT ChEMBL DrugBank Drugs@FDA MeSH PubChem
Back

Drug Pricing Summary

AUS PBS

$6796.6675

VA Big4

$12213.7400

VA FSS

$16184.6700

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
ocrelizumab 300 mg / 10 mL (10 mL INJECTION) $6796.6675 AUS PBS generic
  • Ocrevus (1)
    		•  Roche Products Pty Ltd
    ocrelizumab 300 mg / 10 mL (10 mL INJECTION) $12213.7400 VA Big4
  • OCREVUS (1)
    		•  Genentech USA
    ocrelizumab 300 mg / 10 mL (10 mL INJECTION) $16184.6700 VA FSS
  • OCREVUS (1)
    		•  Genentech USA

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue